Position in ABSI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,800
-$1,764 QoQ
Shares Held
3,600
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rialto Wealth Management, LLC holds $832,682 across 47 Biotechnology names. ABSI ranks #3 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MESO |
Mesoblast Ltd
|
46,500 | $715,170 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
86 | $38,402 | |
| 3 | ABSI |
Absci Corp
This page
|
3,600 | $10,800 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
1,450 | $9,265 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
162 | $8,540 | |
| 6 | GOSS |
Gossamer Bio, Inc.
|
20,552 | $6,761 | |
| 7 | ERAS |
Erasca, Inc.
|
413 | $6,682 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7 | $5,408 |
All Filings in ABSI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,800 | 3,600 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,564 | 3,600 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $10,944 | 3,600 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $9,252 | 3,600 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $9,036 | 3,600 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $9,432 | 3,600 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||